First human test of new cancer drug shows safety profile
Disease control
Completed
This first-in-human study tested the safety of a new oral drug called EVT801 in 32 adults with advanced solid tumors that hadn't responded to standard treatments. Researchers aimed to find the highest safe daily dose that could be used in future studies. The trial also looked at …
Phase: PHASE1 • Sponsor: Kazia Therapeutics Limited • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC